ATS 2019 Virtual Final Program

313 Patients with Stable and Acute Exacerbation of Bronchiectasis Present Increased Platelet Activation/ R. Méndez, A. Moscardó, A. Latorre, P. González-Jiménez, L. Feced, A. Piró, V. Alcaraz, R. Amaro, A. Torres, R. Menéndez, Valencia, Spain, p.A5709 314 Identification and Validation of Biomarkers of Antibiotic Response in Bronchiectasis Using Sputum Proteomic Profiling/ H. Keir, B. Tan, C.J. Fong, A. Dicker, G. Suarez-Cuartin, O. Sibila, M.L. Crichton, A. Cassidy, E.G. Pumphrey, S.M. Finch, T. Fardon, J. Huang, J.D. Chalmers, Dundee, United Kingdom, p.A5710 315 Risk Factors for Haemoptysis in 1804 Adults with Non-Cystic Fibrosis Bronchiectasis in Southwestern China: A Retrospective Cohort Study/ X. Wang, B. Liu, J. Luo, D. Wang, C. Liu, Chengdu, China, p.A5711 316 Risk of Severe Bleeding with Rivaroxaban in Medically Ill Patients with Bronchiectasis/ C. Lipardi, C.G. Elliott, L. Haskell, A. Spyropoulos, G. Raskob, J. Xu, W. Lu, T. Spiro, E.S. Barnathan, Raritan, NJ, p.A5712 317 Inhaled Ciprofloxacin (ARD-3150) in Patients with Non-Cystic Fibrosis Bronchiectasis and Frequent Pulmonary Exacerbations: A Pooled Analysis from ORBIT-3 and ORBIT-4/ J.D. Chalmers, A.M. Davis, G. Tino, I. Gonda, J. Froehlich, Cambridge, United Kingdom, p.A5713 318 Airway Bacterial Load and Response to Inhaled Aztreonam in Bronchiectasis/ O. Sibila Vidal, E. Laserna, A. Shoemark, H.R. Keir, S. Finch, A. Rodrigo-Troyano, L. Perea, P.C. Goeminne, J.D. Chalmers, Barcelona, Spain, p.A5714 319 Dynamic Hyperinflation and Exercise Performance in Non-Cystic Fibrosis Bronchiectasis: Clinical, Radiological and Functional Correlations/ M.C. Maiorano, F.L.A. Fernandes, J.M. Salge, R. Stelmach, A. Cukier, R.A. Athanazio, Sao Paulo, Brazil, p.A5715 320 Pseudomonas Aeruginosa Associated with Severity of Non-Cystic Fibrosis Bronchiectasis Measured by the Modified Bronchiectasis Severity Score (BSI) and the FACED: The US Bronchiectasis and NTM Research Registry (BRR) Study/ R. Choate, T.R. Aksamit, D.M. Mannino, G.A. Stone, D.J. Addrizzo-Harris, A.F. Barker, A. Basavaraj, C.L. Daley, L.A. Daniels, E. Eden, A.M. DiMango, K.P. Fennelly, D.E. Griffith, M.M. Johnson, M.R. Knowles, P.J. McShane, M.L. Metersky, P.G. Noone, A.E. O'Donnell, K.N. Olivier, M.A. Salathe, A. SChmid, B.M. Thomashow, G. Tino, K.L. Winthrop, Lexington, KY, p.A5716 321 Comparison of Medication Delivery from Nebulizers When Coupled to Oscillatory Positive Expiratory Pressure Devices/ J. Suggett, V. Wang, V. Avvamoukova, M. Nagel, London, Canada, p.A5717 322 Two Years of High frequency Chest Wall Oscillation (HFCWO) Outcomes in a Large Registry of Non-CF Bronchiectasis Patients/ T. Barto, D.J. Maselli, S. Daignault, J. Porter, C. Kraemer, G. Hansen, Houston, TX, p.A5718 323 High Frequency Chest Wall Oscillation (HFCWO) Responder Analysis in a Large Registry of Non-CF Bronchiectasis Patients/ T. Barto, D.J. Maselli, S. Daignault, J. Porter, C. Kraemer, G. Hansen, Houston, TX, p.A5719 324 Benefits of Simeox Airway Clearance Technology in Non-Cystic Fibrosis Patients with Bronchiectasis/ P. Sliwinski, D. Klatka, A. Gladzka, L. Morin, K. Iwan, Warsaw, Poland, p.A5720 BEHAVIORAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION C106 PULMONARY REHABILITATION 2:15 p.m. - 4:15 p.m. OMNI DALLAS DOWNTOWN Trinity Ballroom 5-7 (Level 3) Abstract Summaries 2:15-2:45 Viewing/Discussion 2:45-4:15 Chairing: B.W. Carlin, MD, Sewickley, PA M. Steiner, MBBS, MD, Leicester, United Kingdom C.M. Nolan, MSc, PhD, Harefield, United Kingdom 1001 The Importance of Nutritional Support in Lung Transplant Candidates/ K. Chohan, S. Dales, R. Varughese, L. Wickerson, L.G. Singer, B. Stewart, D. Rozenberg, Toronto, Canada, p.A5721 1002 A Web-Based Physical Activity Intervention Benefits Persons with COPD and Low Self-Efficacy: A Randomized Controlled Trial/ S.A. Robinson, E.S. Wan, A. Kantorowski, M.L. Moy, Bedford, MA, p.A5722 1003 A Video Intervention to Increase Pulmonary Rehabilitation Uptake for Patients Hospitalized with Acute Exacerbations of COPD (virtue): A Randomized Controlled Trial/ R.E. Barker, S.E. Jones, W. Banya, S.S.C. Kon, S. Fleming, C.M. Nolan, S. Patel, S.F. Clarke, J.A. Walsh, S.C. Wynne, M. Maddocks, M. Farquhar, J.A. Wedzicha, W. Man, Harefield, United Kingdom, p.A5723 1004 Small Intestinal Dysfunction Attenuates the Anabolic Response to Feeding and Compromises Daily Functioning in Patients with Chronic Obstructive Pulmonary Disease/ S.K. Kirschner, N.E.P. Deutz, R. Jonker, A. McNew-Wierzchowska, S.W.M. Olde Damink, R.I. Harrykissoon, A.J. Zachria, M.P.K.J. Engelen, College Station, TX, p.A5724 1005 How Much to Change Physical Activity and Sedentary Time to Meaningfully Impact Quality-of-Life in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease/ C.N. Driver, P. Novotny, R. Benzo, Rochester, MN, p.A5725 1006 The Effect of Pulmonary Rehabilitation Following Acute Exacerbation of COPD on Cardiovascular Function/ B.A. Ross, D.P. Fuhr, A. Brotto, W. Michaelchuk, S. Henry, L. Morin, S. Schneck, B.H. Rowe, R. Damant, W.P. Ramesh, M. Bhutani, M.K. Stickland, Edmonton, Canada, p.A5726 1007 L-Carnitine Supplementation in COPD Patients Significantly Improved Walking Distance in a Randomized Double-Blinded Pilot Study/ S. Mirza, R. Benzo, Rochester, MN, p.A5727 1008 Theoretical Framework of the Effect of Health Coaching on Quality of Life in COPD/ R. Benzo, P. Novotny, N. Lam, M. Lee, Rochester, MN, p.A5728 1009 Effect of Home Pulmonary Rehab Plus Health Coaching on COPD Self-Management: A Randomized Study/ R. Benzo, J.P. Hoult, B.E. Thomas, N. Lam, S. Seifert, K. Kramer, Rochester, MN, p.A5729 ATS 2019 • Dallas, TX TUESDAY • MAY 21 305 TUESDAY AFTERNOON